论文信息 - Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS) - 字舞流文

Observational study of HR+/HER2− metastatic breast cancer patients treated with abemaciclib in Spain in the Named Patient Use Program (AbemusS)

J. Gavilá | M. Atienza | E. Aguirre | A. Molero | S. Díaz-Cerezo | M. Seguí | J. M. Cervera | Míriam Arumí | S. Blanch | J. Gil-Gil | M. Arumí